Back to Search
RICHARD BURGER, M.D.
M.D.
Infectious Disease Physician
NPI: 1710968243Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
MD16211(AK)
Research & Publications (20)
Experience with bevacizumab in the management of epithelial ovarian cancer.
PMID 17617521·J Clin Oncol·2007
6-review
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study.
PMID 18024863·J Clin Oncol·2007
3-trial
Avian superior olivary nucleus provides divergent inhibitory input to parallel auditory pathways.
PMID 15558730·J Comp Neurol·2005
7-preclinical
Expression of GABA(B) receptor in the avian auditory brainstem: ontogeny, afferent deprivation, and ultrastructure.
PMID 15977167·J Comp Neurol·2005
7-preclinical
Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy: a gynecologic oncology group study.
PMID 15221995·Cancer·2004
3-trial
DICOM - a new approach in medical under- and postgraduate education.
PMID 11715962·Med Educ·2001
8-other
Intra-osseous ultrasound for pedicle screw positioning in the subaxial cervical spine: an experimental study.
PMID 19597760·Acta Neurochir (Wien)·2010
8-other
The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylation.
PMID 19621390·Int J Cancer·2010
7-preclinical
[Aspects of the risks associated with vCJK from plasma derivatives from human plasma].
PMID 19557456·Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz·2009
7-preclinical
Superoxide protects Escherichia coli from bleomycin mediated lethality.
PMID 19679357·J Inorg Biochem·2009
8-other
A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
PMID 18977518·Gynecol Oncol·2009
3-trial
Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.
PMID 19224846·J Clin Oncol·2009
3-trial
Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cells in vitro and in vivo.
PMID 19139110·Mol Cancer Ther·2009
7-preclinical
Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
PMID 19139430·J Clin Oncol·2009
3-trial
Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.
PMID 19110305·Gynecol Oncol·2009
3-trial
Toxic clozapine serum levels during inflammatory reactions.
PMID 19593184·J Clin Psychopharmacol·2009
8-other
[Communications by the Blood Working Group of the Federal Public Health Administration. Measures to prevent transfusion-induced lung failure (TRALI)].
PMID 19407940·Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz·2009
8-other
CD96 interaction with CD155 via its first Ig-like domain is modulated by alternative splicing or mutations in distal Ig-like domains.
PMID 19056733·J Biol Chem·2009
7-preclinical
Decompressive craniotomy: durotomy instead of duroplasty to reduce prolonged ICP elevation.
PMID 19388296·Acta Neurochir Suppl·2008
3-trial
Maintenance treatment with bevacizumab prolongs survival in an in vivo ovarian cancer model.
PMID 19047105·Clin Cancer Res·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 19942 SAINT JOSEPH DRIVE
CENTERVILLE, IA 52544 - Phone
- (641) 856-8684
Quick Facts
- NPI
- 1710968243
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile